Trial Profile
Population pharmacokinetic/pharmacodynamic model for duloxetine in patients with painful diabetic neuropathies
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Oct 2013
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 23 Oct 2013 New trial record